drugset / Trial / NCT03082573
Efficacy, Radiographic and Laboratory Changes in Refractory Rheumatoid Arthritis Patients Treated With H.P. Acthar Gel
RandomizedCrossoverOpen-labelTreatment
Summary
This study will examine the clinical response, cytokine expression and joint imaging after addition of Acthar Gel. The hypothesis is that H.P. Acthar Gel is both safe and effective for treatment of patients with refractory rheumatoid arthritis (RA) and has different mechanism of action than steroids and other DMARDs.
Timeline
- Start
- 2017-03-03
- Primary completion
- 2018-02
- Completion
- 2019-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Acthar | Peptide | 40 iu | — |
| Comparator | Acthar | Peptide | 80 iu | — |